These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 31599039

  • 1. Successful treatment of acquired reactive perforating collagenosis with topical benzoyl peroxide: A possible therapeutic action underlying structural and metabolic turnover.
    Miyanaga M, Oyama N, Sakai Y, Imamura Y, Hasegawa M.
    J Dermatol; 2020 Jan; 47(1):e12-e14. PubMed ID: 31599039
    [No Abstract] [Full Text] [Related]

  • 2. Acquired Perforating Collagenosis in Diabetes Mellitus.
    Gratsias E, Dissemond J.
    Dtsch Arztebl Int; 2018 Jul 09; 115(27-28):462. PubMed ID: 30064625
    [No Abstract] [Full Text] [Related]

  • 3. Effectiveness of topical maxacalcitol for acquired perforating disorder.
    Yoshiya H, Okuyama R, Uhara H.
    J Am Acad Dermatol; 2013 Jun 09; 68(6):e181-2. PubMed ID: 23680211
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acquired reactive perforating collagenosis in a nondiabetic hemodialysis patient: successful treatment with allopurinol.
    Iyoda M, Hayashi F, Kuroki A, Shibata T, Kitazawa K, Sugisaki T, Sakai O.
    Am J Kidney Dis; 2003 Sep 09; 42(3):E11-3. PubMed ID: 12955705
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of acquired reactive perforating collagenosis with itraconazole.
    Ye B, Cao Y, Liu Y.
    Eur J Med Res; 2021 Jul 13; 26(1):74. PubMed ID: 34256825
    [Abstract] [Full Text] [Related]

  • 7. Acquired reactive perforating collagenosis associated with systemic lupus erythematosus.
    Ohashi T, Yamamoto T.
    J Dermatol; 2016 Sep 13; 43(9):1097-9. PubMed ID: 27028318
    [No Abstract] [Full Text] [Related]

  • 8. Acquired reactive perforating collagenosis.
    Schmults CA.
    Dermatol Online J; 2002 Oct 13; 8(2):8. PubMed ID: 12546763
    [No Abstract] [Full Text] [Related]

  • 9. Acquired reactive perforating collagenosis: A case report and review of the literature.
    Zhang X, Yang Y, Shao S.
    Medicine (Baltimore); 2020 May 29; 99(22):e20391. PubMed ID: 32481426
    [Abstract] [Full Text] [Related]

  • 10. A giant variant of acquired reactive perforating collagenosis associated with hydronephrosis: successful treatment with allopurinol.
    Gnanaraj P, Venugopal V, Sangitha C, Rajagopalan V, Pandurangan CN.
    Int J Dermatol; 2009 Feb 29; 48(2):204-6. PubMed ID: 19200207
    [No Abstract] [Full Text] [Related]

  • 11. Acquired reactive perforating collagenosis.
    Chhabra N, Sharma S.
    Skinmed; 2013 Feb 29; 11(5):318-9. PubMed ID: 24340478
    [No Abstract] [Full Text] [Related]

  • 12. Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide.
    Dubina MI, Fleischer AB.
    Arch Dermatol; 2009 Sep 29; 145(9):1027-9. PubMed ID: 19770443
    [Abstract] [Full Text] [Related]

  • 13. Reactive perforating collagenosis during erlotinib therapy.
    Suzuki Y, Yamamoto T.
    Acta Derm Venereol; 2012 Mar 29; 92(2):216-7. PubMed ID: 22101862
    [No Abstract] [Full Text] [Related]

  • 14. Acquired reactive perforating collagenosis.
    Kreuter A, Gambichler T.
    CMAJ; 2010 Mar 09; 182(4):E184. PubMed ID: 20159897
    [No Abstract] [Full Text] [Related]

  • 15. A case report on acquired reactive perforating collagenosis.
    Su Y, Cui W.
    Medicine (Baltimore); 2024 Jul 19; 103(29):e39071. PubMed ID: 39029035
    [Abstract] [Full Text] [Related]

  • 16. Acquired reactive perforating collagenosis.
    Cohen RW, Auerbach R.
    J Am Acad Dermatol; 1989 Feb 19; 20(2 Pt 1):287-9. PubMed ID: 2915063
    [No Abstract] [Full Text] [Related]

  • 17. Topical dose justification: benzoyl peroxide concentrations.
    Brandstetter AJ, Maibach HI.
    J Dermatolog Treat; 2013 Aug 19; 24(4):275-7. PubMed ID: 22103743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acquired reactive perforating collagenosis in association with prostate adenocarcinoma, chronic lymphocytic leukemia, and Graves' disease.
    Huseynova L, Akdogan N, Gököz Ö, Evans SE.
    An Bras Dermatol; 2020 Aug 19; 95(3):336-339. PubMed ID: 32359703
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.